Therapeutic Patient Education and Cancer Pain (EFFADOL)

THERAPEUTIC PATIENT EDUCATION AND CANCER PAIN

Describe the expectations of therapeutic education for patients in management of cancer pain.

Study Overview

• Status: Completed
• Conditions: Cancer
• Intervention / Treatment: Other: Questionnaire

• Study Type: Observational
• Enrollment (Actual): 75

Contacts and Locations

Study Locations

• France
  • Caen, France
    • Centre Francois Baclesse

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

• Sampling Method: Probability Sample

Study Population

Patients with cancer and pain

Description

Inclusion Criteria:

• Patient with cancer diagnosed for at least one month
• Patient with pain from the tumor or its treatment
• Patients with a life expectancy ≥ 6 months
• Health condition compatible with the requirements of the program (WHO performance scale < or= 2)
• Age over 18 years
• Patient able to understand, speak and read French
• Absence of cognitive impairment

Exclusion Criteria:

• Primary cancer of the central nervous system or brain metastases
• Disorders of the documented higher functions
• Evolutionary psychiatric pathology
• Drug User
• Abusive alcohol consumption than the WHO recommendations (or 3 glasses of wine per day)
• Refusal to participate

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Time Frame
describe the expectations of therapeutic education for patients in management of cancer pain	at inclusion

Secondary Outcome Measures

Outcome Measure	Time Frame
Describe the expectations of close person in therapeutic education on management of cancer pain	at inclusion
Estimate the intensity of the pain	at inclusion
Estimate the echo of the pain on the daily activity of the patient	at inclusion

Collaborators and Investigators

• Sponsor: Centre Francois Baclesse

Study record dates

Study Major Dates

• Study Start: February 1, 2015
• Primary Completion (Actual): February 1, 2016
• Study Completion (Actual): February 1, 2016

Study Registration Dates

• First Submitted: March 12, 2015
• First Submitted That Met QC Criteria: March 17, 2015
• First Posted (Estimate): March 18, 2015

Study Record Updates

• Last Update Posted (Estimate): March 4, 2016
• Last Update Submitted That Met QC Criteria: March 3, 2016
• Last Verified: March 1, 2016

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Pain; Neurologic Manifestations; Cancer Pain
• Other Study ID Numbers: 2014-A00239-38